Nivolumab versus everolimus in advanced renal-cell carcinoma

Robert J. Motzer, Bernard Escudier, David F. McDermott, Saby George, Hans J. Hammers, Sandhya Srinivas, Scott S. Tykodi, Jeffrey A. Sosman, Giuseppe Procopio, Elizabeth R. Plimack, Daniel Castellano, Toni K. Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas C. Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A. SchutzChristian Kollmannsberger, James Larkin, Alain Ravaud, Jason S. Simon, Li An Xu, Ian M. Waxman, Padmanee Sharma

Research output: Contribution to journalArticlepeer-review

3234 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab versus everolimus in advanced renal-cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences